Zhejiang Hisun Biomaterials Co.Ltd.

SHSE:688203 Stock Report

Market Cap: CN¥2.0b

Zhejiang Hisun BiomaterialsLtd Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Zhiming Chen

Chief executive officer

CN¥1.0m

Total compensation

CEO salary percentagen/a
CEO tenure19.8yrs
CEO ownership1.2%
Management average tenureno data
Board average tenure3.3yrs

Recent management updates

Recent updates


CEO

Zhiming Chen (61 yo)

19.8yrs

Tenure

CN¥1,038,200

Compensation

Mr. Zhiming Chen is General Manager and Director of Zhejiang Hisun Biomaterials Co.Ltd. from August 2004.


Board Members

NamePositionTenureCompensationOwnership
Guoping Jiang
Legal Representative & Chairman3.8yrsno datano data
Zhiming Chen
GM & Director19.8yrsCN¥1.04m1.22%
CN¥ 24.8m
Ran Liu
Independent Director3.3yrsCN¥80.00kno data
Song Peng
Independent Director3.3yrsCN¥80.00kno data
Yu Qiu
Independent Director3.3yrsCN¥80.00kno data
Jianxiang Wang
Independent Director3.3yrsCN¥80.00kno data
Wei Xu
Chairman of the Supervisory Board3.3yrsno datano data

3.3yrs

Average Tenure

60yo

Average Age

Experienced Board: 688203's board of directors are considered experienced (3.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.